Clinical trial Recruiting at 3 sites Phase 2 Interventional Ages 18 to 75

Understanding exercise capacity and blood pressure response in chronic kidney disease

Official title: Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease

Run by Emory University · NCT02947750 · Data updated 2026-11-12

This study is testing if a new exercise program and some supplements can help people with chronic kidney disease improve their ability to exercise and manage their blood pressure better.

More Renal Insufficiency, Chronic trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment150 (estimated)
SponsorEmory University
Academic / other
Locations3 sites (Atlanta, Georgia and 2 other locations)
StatusRecruiting
StartedOctober 2016
Main results expectedApril 30, 2027
Study endsApril 30, 2027
Registry record updatedMay 18, 2026
Trial IDNCT02947750 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with Stage III or IV chronic kidney disease who do not exercise regularly.

Probably not a fit

Patients with severe chronic kidney disease, ongoing substance abuse, or serious systemic diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate the reasons behind poor exercise capacity and increased blood pressure during exercise in patients with chronic kidney disease (CKD). It will explore the effects of aerobic exercise training and the administration of 6R-BH4, a drug currently approved for phenylketonuria, along with histidine and beta-alanine supplementation. Researchers will measure vascular reactivity, muscle pH, and oxygenation during exercise to understand the underlying mechanisms. The study will include both CKD patients and control participants who do not exercise regularly.

Why it matters

Potential benefit: If successful, this study could improve exercise capacity and cardiovascular health in patients with chronic kidney disease.

How similar studies have gone: Other studies have shown promising results in improving exercise capacity and vascular health in CKD patients through similar interventions, but the specific combination of treatments in this study is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for Chronic Kidney Disease Patients:

* Stage III or IV Chronic Kidney Disease, defined as reduction in estimated glomerular filtration rate (eGFR) to 15-59 cc/minute as calculated by the modified Modification of Diet in Renal Disease (MDRD) Study equation or the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
* Stable renal function, with no greater than a 30% reduction in eGFR over the prior 3 months
* Does not exercise regularly (defined as exercising less than 20 minutes twice per week)
* Willing and able to cooperate with the study protocol

Inclusion Criteria for Control Study Participants:

* Does not exercise regularly (defined as exercising less than 20 minutes twice per week)
* Willing and able to cooperate with the study protocol

Exclusion Criteria:

* severe CKD (eGFR\<15 cc/minute)
* ongoing drug or alcohol abuse
* diabetic neuropathy
* any serious systemic disease that might influence survival
* severe anemia with hgb level \<9 g/dL
* clinical evidence of congestive heart failure or ejection fraction below 35%
* symptomatic heart disease determined by prior electrocardiogram, stress test, and/or history
* treatment with central alpha agonists (clonidine)
* uncontrolled hypertension with BP greater than 170/100 mm Hg
* low blood pressure with BP less than 100/50
* pregnancy or plans to become pregnant
* current treatment with monoamine oxidase (MAO) inhibitors
* inability to exercise on a stationary bicycle

Where it's running

  • Emory University Hospital Midtown
    Atlanta, Georgia, United States
    Recruiting
  • Emory University Hospital
    Atlanta, Georgia, United States
    Recruiting
  • Atlanta VA Health Care System
    Decatur, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.